viewCello Health PLC

Cello Health launches in Germany with new Berlin office, appoints regional directors

Jane Shirley, chief executive of the healthcare-focused consultancy, said the new branch in mainland Europe would provide additional ground support to its continental clients

German flag
The Berlin office will headquarter the company's new entity, Cello Health Insight Germany

Cello Health PLC (LON:CLL) has launched its German branch with a new office in Berlin while also appointing two regional directors.

The healthcare-focused consultancy said on Monday that the two regional directors were Heike Tombrink, who was also appointed head of Cello Health Insight Germany, and Matthias Heurich, who would be supporting digital innovation.

READ: Cello Health expects 'robust' profits growth in first half

Tombrink has prior experience in leading small and large teams in and outside of matrix organisations  - that is where some individuals sometimes report to more than one leader - while Heurich specialises in applied machine learning and artificial intelligence for natural language processing.

Commenting on the news, Jane Shirley, Cello’s chief executive, said the new branch in mainland Europe would bring “a number of benefits” while also serving as a first step in providing additional ground support for the company’s European clients and allowing access to a wider talent pool.

In lunchtime trading on Tuesday, Cello shares were 1.2% lower at 122p.

Quick facts: Cello Health PLC

Price: 148.5 GBX

Market: AIM
Market Cap: £157.89 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...



Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19

2 min read